Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
IRBM to Disclose Strong Antitumor Efficacy of Novel Preclinical Agents Against Aggressive Brain Tumors and Acute Lymphoblastic Leukemia at AACR 2024-04-04 21:00
MEDLEY Opens Philippines Office to Support Global Growth 2024-04-04 10:59
YS Biopharma Announces Full Repayment of US$40,000,000 Loan Facility 2024-04-03 20:00
Ascletis Announces Strategic Decisions on FXR agonist ASC42 2024-04-03 17:10
Tianlong Participated in International Medical Congress of SCO Countries in Kyrgyzstan 2024-04-03 16:16
Great Place To Work unveils Top 10 Best Workplaces in Singapore Healthcare and Biopharma™ 2024 2024-04-03 12:00
RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome 2024-04-03 11:14
Latvian pharmaceutical manufacturing company Grindeks opens new subsidiaries worldwide 2024-04-03 05:00
GC Cell to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024 2024-04-02 23:00
First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH 2024-04-02 20:00
CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO 2024-04-02 17:33
Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status 2024-04-02 13:00
Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY 2024-04-02 11:31
23WELL, THE health supplement brand on the watch 2024-04-02 09:07
Aculys Pharma Announces Appointment of Hidemasa Tanigaki as New CEO 2024-04-01 14:30
LISCure Biosciences receives U.S. FDA Fast Track designation for LB-P8 for the treatment of primary sclerosing cholangitis (PSC) 2024-03-29 21:00
73% CNS ORR! FDA Granted ODD to Utidelone Injectable (UTD1) from Biostar Pharma for the Treatment of Breast Cancer Brain Metastasis 2024-03-29 20:40
Alebund's Innovative Investigational Drug AP303 Receives FDA Orphan Drug Designation (ODD) for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) 2024-03-29 20:00
IASO Bio Announces NMPA's IND Approval for Equecabtagene Autoleucel in Second- and Third-Line Treatment of Multiple Myeloma 2024-03-29 17:20
Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights 2024-03-29 10:42
1 3 4 5 6 7 374